Gestational diabetes & diabetes in pregnancy

A Diabetes Management Protocol with Subcutaneous Insulin During Induced Labor and Delivery in Women with Type 1 or Type 2 Diabetes

Diabetes Technol TherPublished Secondary analysis of the CopenFast trial

Authors' conclusion

Following a diabetes management protocol with subcutaneous insulin during induction and active labor, glucose control was close to target, with low prevalence of maternal and neonatal hypoglycemia.

Study context

Population
Women with T1D or insulin-treated T2D undergoing induction of labor
Participants
113 women
Comparison
T1D vs T2D under a subcutaneous insulin diabetes management protocol
  • T1Dn = 85
  • T2Dn = 28
Primary endpoint
Maternal glucose control and neonatal outcomes
Methodological detailsTarget glucose 4.0-7.0 mmol/L from onset of active labor with IV glucose infusion (3 g/h); MDI users stopped routine insulin, nonautomated pump users continued basal insulin; supplemental insulin if above target
  • Target glucose 4.0-7.0 mmol/L from onset of active labor with IV glucose infusion (3 g/h); MDI users stopped routine insulin, nonautomated pump users continued basal insulin; supplemental insulin if above target

Primary result

As reported in the abstract

Mean glucose during active labor (sensor glucose in T1D; BGM in T2D)

Further findings

HbA1c at 35 weeks

HbA1c, mean ± SD, in the order the abstract prints them (85 T1D and 28 T2D)
42 ± 5 and 41 ± 10 mmol/mol (6.0 ± 2.0% and 5.9 ± 2.0%)
  • The abstract does not name the group for each value.

Duration of glucose infusion

Glucose infusion duration, median (IQR), in the order the abstract prints them
4.8 (2.0-7.0) and 5.5 (4.0-8.0) hours
  • The abstract does not name the group for each value.

Supplemental insulin during active labor

Supplemental insulin given, % (dose, median [IQR]), in the order the abstract prints them
35% (4.0 IU [2.0-7.5]) and 18% (2.0 IU [2.0-4.0])
  • The abstract does not name the group for each value.

Safety

Maternal hypoglycemia (≤3.9 mmol/L [70 mg/dL]) · active labor

Maternal hypoglycemia, in the order the abstract prints them
6% and 11%
  • The abstract does not name the group for each value.

Neonatal hypoglycemia (<2.2 mmol/L [40 mg/dL])

Neonatal hypoglycemia, in the order the abstract prints them
12% and 4%
  • The abstract does not name the group for each value.

Original publication

A Diabetes Management Protocol with Subcutaneous Insulin During Induced Labor and Delivery in Women with Type 1 or Type 2 Diabetes. Diabetes Technol Ther. Published 9 July 2026. doi:10.1177/15209156261466030

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.